Eton Pharmaceutcials
ETON
48 hedge funds and large institutions have $60M invested in Eton Pharmaceutcials in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 9 closing their positions.
18,156% more call options, than puts
Call options by funds: $1.64M | Put options by funds: $9K
109% more capital invested
Capital invested by funds: $28.7M → $60M (+$31.3M)
71% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 7
33% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 9
7% more funds holding
Funds holding: 45 → 48 (+3)
4.75% more ownership
Funds ownership: 33.94% → 38.7% (+4.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.39M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.63M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1.01M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$542K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$245K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$362K |
| 2 |
Goldman Sachs
New York
|
-$189K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$143K |
| 4 |
Squarepoint
New York
|
-$136K |
| 5 |
Renaissance Technologies
New York
|
-$97.6K |
ETON Hedge Fund Activity: Q3 2024 in Review
48 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2024, worth a combined $60M — up 109% from $28.7M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ETON positions and 9 closed out — a net gain of 3 holders — while 12 added to existing stakes and 7 trimmed.
The largest buyer was EcoR1 Capital, opening a new position worth an estimated $2.39M. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $362K sold.
- 48 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2024, up from 45 in Q2 2024.
- Funds reported $60M of Eton Pharmaceutcials stock for Q3 2024, up 109% quarter-over-quarter.
- 12 funds opened new Eton Pharmaceutcials positions in Q3 2024 and 9 closed out, a net change of +3 holders.
- The largest Eton Pharmaceutcials buyer in Q3 2024 was EcoR1 Capital, an estimated $2.39M added.
- The largest Eton Pharmaceutcials seller in Q3 2024 was Stonepine Capital Management, an estimated $362K sold.
Based on aggregated 13F filings for Q3 2024.